Houston, Texas--(Newsfile Corp. - July 20, 2026) - Alzheimer's disease is not only a scientific challenge; it is a human crisis affecting millions of patients, families, caregivers, and healthcare systems. Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) is responding through an intranasal nanoemulsion platform designed to explore new possibilities in neurodegenerative care through cannabinoid-based and natural-compound science.CBIH's invention centers on an intranasal medicine...

Houston, Texas--(Newsfile Corp. - July 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that the State of Texas has approved the Company's license to manufacture and distribute consumable hemp products. This approval turns years of vision, science, and preparation into action and marks the moment CBIH steps into the market and begins commercial distribution.The Company expects...

Houston, Texas--(Newsfile Corp. - July 6, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announces that Dante Picazo, Chief Executive Officer of the Company, has designated 500,000,000 shares of common stock from his personal holdings to honor the directors, employees, and key associates whose dedication, loyalty, and work have helped shape CBIH's journey and strengthen the Company through years of...

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today the launch of its Evidence Sprint 2026, an intensive execution phase designed to turn cannabinoid science into usable medical evidence: protocols, operational collaboration, and projects ready for competitive funding.CBIH confirms receipt of a communication from the Centers for Medicare &...

Cannabis Facts You Didn’t Know (Some of these might surprise you. Some might just make you nod knowingly.) At PhenomWell, we talk about cannabis every day — but there’s always more to learn, even for…

No description available

This cohort study evaluates whether participation in the New York State medical cannabis program is associated with reduction in prescription opioid use among adults with chronic pain.

This is a new hypothesis paper with an interesting idea about autoimmune disease. These conditions are rising nationwide and globally, and the authors suggest that the endocannabinoid system may be pl...

The endogenous cannabinoid system (ECS) is a complex network that plays a crucial role in various physiological processes, and its modulation through …

Yo, even though people often say “cannabinoids are anti-inflammatory”, the truth is that THC probably isn’t a powerful anti-inflammatory drug. CBD, on the other hand actually has some evidence sugges...

A new study shows that prenatal disruption of the endocannabinoid system can have long-lasting effects on brain structure and behavior.

Throwing it back to another hit infographic from The Cannigma Should we to update this to include flavorants like cannasulfur compounds (CSCs), and maybe even some newly discovered alkaloids?!

“Cannabis products containing high concentrations of delta-9-tetrahydrocannabinol (THC) -- the main psychoactive compound in marijuana -- were linked to psychosis, schizophrenia, and addiction, a syst...